World News

/

Matters of Communication: Handelsblatting the Oxford-AstraZeneca Vaccine

The Oxford-AstraZeneca COVID-19 vaccine is fast becoming a subject of notoriety. First, will States obtain it? Second, will they use it? The first answer has generally been affirmative, given the vaccine’s ease of storage and relative cheapness.